Clinical trial
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT02400190
Study timeline
Study start (actual)2015-05-27Date precision: day
Registry last updated2026-06-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Neoplasmsunresolved
Interventions
Sponsors & collaborators
University of Michigan Rogel Cancer Centerlead sponsor
Rutgers Cancer Institute of New Jerseycollaborator
East Carolina Universitycollaborator
Stanford Universitycollaborator
Harvard Universitycollaborator
Yale Universitycollaborator
University of Pennsylvaniacollaborator
Medical College of Wisconsincollaborator
Memorial Sloan Kettering Cancer Centercollaborator
University of Texas Southwestern Medical Centercollaborator
Johns Hopkins Universitycollaborator
Loyola Universitycollaborator
Mapped research locations
New YorkNew York, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1Ann ArborMichigan, United States1New HavenConnecticut, United States1MilwaukeeWisconsin, United States1StanfordCalifornia, United States1New BrunswickNew Jersey, United States1GreenvilleNorth Carolina, United States1MaywoodIllinois, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02400190 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.